PHARMACEUTICALS

Market Highlights: Increasing prevalence of the lazy eye diseases, growing child population, rising healthcare expenditures, and increasing R&D by the major market players are estimated to be the major drivers governing the market growth during the forecast period. However, lack of awareness and unavailability of the effective treatment procedures may restrain the market growth during the projected period. The global Lazy Eye Market is expected to grow at an approximate CAGR of 7.8% during the forecast period. Key Players: ·          Pfizer Inc ·          TCI Chemicals (India) Pvt. Ltd ·          Adwia Pharmaceuticals Co ·          3M ·          Bausch & Lomb Incorporated ·          Rebion ·     ...

  Knee Bursitis Market – Overview: The increased incidence of bone-related diseases like knee bursitis is gaining momentum at present. Reports that appraise the pharmaceutical industry have been presented by Market Research Future, which creates reports on industry verticals that assess the market development and prospects. The Knee Bursitis Treatment Market is anticipated to tap into a CAGR of 7.1% in the upcoming forecast period. Increased pressure on the knees duet o rigorous activities is increasing the detection of knee bursitis cases. Moreover, the increased availability of treatment options is expected to enhance market development in the forecast period. Also, an increased presence of risk factors that cause knee bursitis is expected to increase the development of the market in the forecast period. Competitive Analysis: The beneficial nature of the monetary and fiscal policies is expected to tip towards strong growth in the market. The economies around the w...

Market Highlights: Reye’s Syndrome is a rare disease that causes swelling of the liver and brain. Increasing prevalence of influenza and rising teenage population are the major drivers of the Reye’s Syndrome Treatment Market . Moreover, increasing per capita healthcare expenditure and developing biotechnology & pharmaceutical industries within the developing economies across the world are estimated to boost the market growth during the forecasted period. However, lack of awareness, limited treatment options, and FDA approvals may restrain the market growth during the forecast period. Key Players: ·          General Electric Company ·          Siemens Healthcare Gmbh ·          CANON MEDICAL SYSTEMS CORPORATION ·          Koninklijke Philips N.V. ·          NeuroL...

Market Highlights: Truncus arteriosus is a rare congenital cardiovascular disease. In this condition, the embryological structure known as the truncus arteriosus fails to properly divide into the pulmonary trunk and aorta. Increasing prevalence of cardiovascular diseases, adoption of advanced techniques in diagnosis, and increasing government support is driving the growth of the market. According to the World Health Organization, 422 million people across the globe are suffering from diabetes. Diabetes is the major reason for cardiovascular diseases. Increasing prevalence of diabetes, rapidly developing technology, across the globe is further fuelling the growth of the market. However, higher cost of the treatment methods may slow the growth of the Truncus Arteriosus Market over the assessment period.  Key Players:                          ...

Market Overview: Cochlear implants are medical devices that are surgically inserted to provide a sense of sound to a person with hearing loss. The last few years have witnessed a significant increase in the demand for cochlear implants owing to the rise in a number of patients with hearing impairment who generate demand for diagnosis and treatment. The global Cochlear Implants Market anticipated to grow at a CAGR of 9.86% and is due to reach USD 3,203.8 Mn over the forecast period of 2017-2023 , projects Market Research Future (MRFR) in a detailed report. Cochlear implants can be referred to as medical devices that are inserted surgically in order to offer a sense of sound to a person suffering from hearing loss. The cochlear implants market has witnessed a tectonic surge over the past few years due to the rising number of suffering from hearing impairment. As per the CDC, around 900 million people are predicted to suffer from hearing impairment by the end of 2025. Gr...

Market Overview: This anticoagulant can be considered as a drug that often finds action in surgeries or other treatments as a method that stops the blood from clotting. These anticoagulants act by suppressing the synthesis of various functions of clotting factors that can be found in the blood. These drugs find significant usage in the cases where the blood gets clotted in arteries or veins and smooth operation of that is much needed. In cases like where a blood clot starts floating in the system and has the chances of getting big, these drugs are used to make sure that the flow becomes normal. The global Oral Anticoagulants Market is showing substantial potential in garnering a CAGR of 12.50%  to surpass a predicted valuation of USD 22,561.24 million between 2015 and 2023, which can be deemed as the forecast period. There are several factors playing in favor of the global market for oral anticoagulants. These are rising numbers of cardiovascular disorders, a ...